Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.
This new 900-page five-country market intelligence and technology assessment report from Venture Planning Group will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.
The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. However, this evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Table of Contents
II. Worldwide Technology and Market Overview
A. Major Routine Chemistry Tests
B. Therapeutic Drug Monitoring (TDM)
C. Endocrine Function Tests
D. Tumor Markers and Special Chemistry Tests
E. Immunoprotein Tests
F. Drug of Abuse
G. Instrumentation Review: Operating characteriscs
and features of high-, medium-, and low-volume/POC
H. Major In Vitro Diagnostic Technologies
and Their Potential Applications
III. France IV. Germany
VI. Spain VII. U.K.
VIII. Major Product Development Opportunities
IX. Design Criteria for Decentralized Testing Products
X. Alternative Market Penetration Strategies
XI. Potential Market Entry Barriers and Risks
Contains 900 pages and 335 tables